Company Analysis Pharmaron Beijing Co., Ltd.
1. Summary
Advantages
- Current debt level 0% is below 100% and has decreased over 5 years from 7.63%.
- The company's current efficiency (ROE=13.56%) is higher than the sector average (ROE=11.95%)
Disadvantages
- Price (20.69 Β₯) is higher than fair price (15.23 Β₯)
- Dividends (0.99%) are below the sector average (1.83%).
- The stock's return over the last year (-64%) is lower than the sector average (-23.91%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Pharmaron Beijing Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 4.5% | 7.8% | 1.3% |
| 90 days | -4.7% | -10.6% | 5.6% |
| 1 year | -64% | -23.9% | 26.6% |
300759 vs Sector: Pharmaron Beijing Co., Ltd. has significantly underperformed the "Healthcare" sector by -40.09% over the past year.
300759 vs Market: Pharmaron Beijing Co., Ltd. has significantly underperformed the market by -90.6% over the past year.
Stable price: 300759 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 300759 with weekly volatility of -1.23% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (20.69 Β₯) is higher than the fair price (15.23 Β₯).
Price is higher than fair: The current price (20.69 Β₯) is 26.4% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (31.82) is lower than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (31.82) is lower than that of the market as a whole (63.57).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (4.3) is higher than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (4.3) is higher than that of the market as a whole (3.79).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (4.31) is lower than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (4.31) is lower than that of the market as a whole (5.87).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (24.23) is higher than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (24.23) is lower than that of the market as a whole (25.54).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 5.08% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (5.08%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
6.4. ROE
ROE vs Sector: The company's ROE (13.56%) is higher than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (13.56%) is higher than that of the market as a whole (9.38%).
6.6. ROA
ROA vs Sector: The company's ROA (5.54%) is higher than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (5.54%) is higher than that of the market as a whole (3.95%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.99% is below the average for the sector '1.83%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.99% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0.99% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (36.12%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
